|
USP18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00770000011075E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.37009999998406E-06 |
| Normal-vs-Stage2 |
1.123020E-01 |
| Normal-vs-Stage3 |
1.383890E-03 |
| Normal-vs-Stage4 |
6.442200E-02 |
| Stage1-vs-Stage2 |
5.477400E-01 |
| Stage1-vs-Stage3 |
7.916200E-01 |
| Stage1-vs-Stage4 |
7.651800E-01 |
| Stage2-vs-Stage3 |
6.642200E-01 |
| Stage2-vs-Stage4 |
8.080000E-01 |
| Stage3-vs-Stage4 |
9.040800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.31759999999426E-05 |
| Normal-vs-AfricanAmerican |
5.682400E-03 |
| Normal-vs-Asian |
5.660700E-03 |
| Caucasian-vs-AfricanAmerican |
3.661500E-02 |
| Caucasian-vs-Asian |
2.625600E-01 |
| AfricanAmerican-vs-Asian |
1.256040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.675050E-03 |
| Normal-vs-Female |
1.06209999994888E-06 |
| Male-vs-Female |
8.777400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.430700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.15879999999613E-05 |
| Normal-vs-Age(61-80Yrs) |
1.227040E-01 |
| Normal-vs-Age(81-100Yrs) |
4.642600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.147800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.963370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.626800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.691600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.570400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.533000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.303600E-01 |
| Classical-VS-Follicular |
1.329810E-01 |
| Classical-VS-Other |
2.361400E-01 |
| Classical-VS-Normal |
8.08500000282208E-09 |
| Tall-VS-Follicular |
7.700000E-01 |
| Tall-VS-Other |
3.245600E-01 |
| Tall-VS-Normal |
5.694100E-02 |
| Follicular-VS-Other |
6.043200E-01 |
| Follicular-VS-Normal |
1.485390E-01 |
| Other-VS-Normal |
9.123000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.831000E-04 |
| Normal-vs-N1 |
1.254200E-01 |
| N0-vs-N1 |
3.674400E-01 |
|
|
